𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in diabetic patients: Prospective randomized multicenter trial

✍ Scribed by Soon Jun Hong; Moo Hyun Kim; Kwang Soo Cha; Hun Sik Park; Shung Chull Chae; Seung Ho Hur; Hyeon Cheol Gwon; Jang Ho Bae; Do-Sun Lim

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
290 KB
Volume
76
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-year clinical outcomes of sirolimus
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients
✍ K. Anette Birkmeier; Adnan Kastrati; Robert A. Byrne; Heidrun Holle; Stefanie Sc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 1 views

## Abstract Objectives and Background: First generation drug‐eluting stents have shown differential efficacy in high‐risk patient subsets at one year. It is unclear whether these differences endure over the medium‐ to long‐term. We compared the five‐year clinical efficacy and safety of sirolimus‐el

Impact of three or more sirolimus-elutin
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with ≥3 sirolimus‐eluting stents (SES) when compared with those treated with ≥3 paclitaxel‐eluting stents (PES). ## Background: Drug‐eluting stent (DES) implantation for s